Table 1.
Characteristics of the included studies with risk of bias.
Fig 1.
PRISMA flow chart of the literature search and study selection.
Fig 2.
Table 2.
SARS-CoV-2 related oral manifestation latency time, duration, and therapy.
Table 3.
SARS-CoV-2 related oral mucocutaneous lesions clinical appearance, locations, and differential diagnosis.